Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.
CUE
$25.57
+1.27%
CUE
· Cue Biopharma, Inc.
$25.57
+0.32 (+1.27%)
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— cleared Aug 14, 2026
The latest filing no longer states the doubt (first flagged May 14, 2026).
View the 10-Q filed Aug 14, 2026Market Cap
$194.11M
Shares
7.26M
Volume · Oct 2
157.04K
Avg daily vol (3M)
264.91K
All webcasts
Earnings call · FY2024 Q4
Cue Biopharma, Inc. (CUE) Q4 2024 Earnings Call
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Revenue · derived Q4
$1.58M
-13.5% YoY
Net income · derived Q4
-$9.50M
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Mar 31, 2025 · complete as-filed document
SEC periodic report
10-K report
Filed Mar 31, 2025 · complete as-filed document